QuidelOrtho Corporation
QDEL
$0.16 (-0.87%)
1D
1W
3M
1Y
5Y
ALL
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
PRNewsWire • 11 days ago • QDEL
QuidelOrtho to Report Second Quarter 2026 Financial Results
Zacks Investment Research • 12 days ago • QDEL
Reasons to Add QuidelOrtho Stock in Your Portfolio for Now
PRNewsWire • 12 days ago • QDEL
Beyond Fentanyl: How the Drug Crisis Is Changing
Business Wire • 12 days ago • QDEL
Kaskela Law Firm Announces Investigation of QuidelOrtho Corp. (QDEL) and Encourages Long-Term QDEL Shareholders with Investment Losses to Contact the Firm
Zacks Investment Research • 15 days ago • QDEL
4 Medical Products Stocks Poised to Win Despite Industry Headwinds
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.